Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.392
-0.003 (-0.63%)
At close: Mar 9, 2026, 4:00 PM EDT
0.385
-0.006 (-1.61%)
After-hours: Mar 9, 2026, 7:41 PM EDT
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $62.32 million as of March 9, 2026. Its market cap has decreased by -85.98% in one year.
Market Cap
62.32M
Enterprise Value
14.94M
1-Year Change
-85.98%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $62.32M, a decrease of -50.08%. That is a compound annual growth rate of -9.62%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InflaRx | 65.71M |
| Q32 Bio | 65.66M |
| TScan Therapeutics | 63.73M |
| ImageneBio | 62.84M |
| eXoZymes | 61.43M |
| NeurAxis | 60.83M |
| Instil Bio | 60.16M |
| Spruce Biosciences | 59.80M |